Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: Mutations or polymorphisms?

Citation
Y. Muller-koch et al., Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: Mutations or polymorphisms?, EUR J MED R, 6(11), 2001, pp. 473-482
Citations number
19
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology
Journal title
EUROPEAN JOURNAL OF MEDICAL RESEARCH
ISSN journal
09492321 → ACNP
Volume
6
Issue
11
Year of publication
2001
Pages
473 - 482
Database
ISI
SICI code
0949-2321(20011120)6:11<473:SRSVOT>2.0.ZU;2-V
Abstract
5-8% of all colorectal cancer cases are assumed to be due to germline mutat ions in DNA mismatch repair genes. Mutation analysis of these genes in affe cted families enables one to identify subjects with an inborn susceptibilit y to colorectal tumorogenesis and to offer presymptomatic testing to family members at risk, provided that the mutation detected is a truncating one o r a missense mutation that has either been judged as disease causing in oth er families or segregates with the disease and results in a microsatellite instability of the corresponding tumor. Segregation analysis within the family or microsatellite analysis of the tu mor is, however, not always possible. In these cases, assessment of the rel evance of the sequence variation identified is very difficult. On the other hand, discrimination between inactivating mutations and innocuous sequence polymorphisms is of extreme importance or clinical and genetic counseling of affected families. Here we report 16 rare sequence variants of the hMLH1 and hMSH2 genes inclu ding 11 different missense variations found in a cohort of 254 suspected HN PCC patients. We provide evidence, that missense variations in hMLH1 do not necessarily result in microsatellite instability of the corresponding tumo r DNA. These patients would have been missed had one followed the recommend ations of using only microsatellite analysis for the selection of patients at high risk of hereditary non-polyposis colorectal cancer for mutation ana lysis.